HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Previous close
$0.32
Day range
$0.31 - $0.33
Year range
$0.14 - $0.45
Market cap
572.50M AUD
Avg Volume
5.75M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 845.78K | 2,753.22% |
Operating expense | 3.74M | 90.08% |
Net income | -4.20M | -84.39% |
Net profit margin | -496.73 | 93.54% |
Earnings per share | — | — |
EBITDA | -4.20M | -86.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.31M | 673.71% |
Total assets | 112.46M | 352.83% |
Total liabilities | 3.73M | 97.99% |
Total equity | 108.73M | — |
Shares outstanding | 1.81B | — |
Price to book | 5.25 | — |
Return on assets | -9.41% | — |
Return on capital | -9.73% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.20M | -84.39% |
Cash from operations | -2.18M | 31.16% |
Cash from investing | -1.61M | -66.06% |
Cash from financing | 34.17M | 620.67% |
Net change in cash | 30.50M | 3,874.53% |
Free cash flow | -2.78M | -42.87% |
About
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Founded
1984
Website
Employees
11
